Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs56404434 | chr16:27808124 | T/C | 1.04E-5 | 133 | 46.53 | 33.55 | 17.27 | KM Plot |
| TGCT | rs56406502 | chr10:27558316 | A/G | 6.98E-7 | 132 | 42.18 | 46.3 | 20.6 | KM Plot |
| TGCT | rs56413502 | chr4:154721784 | T/A | 9.98E-5 | 132 | 40.57 | 49.93 | 50.9 | KM Plot |
| TGCT | rs564685 | chr13:21846879 | A/G | 5.93E-7 | 132 | 46.3 | 36.7 | 14.42 | KM Plot |
| TGCT | rs566364 | chr13:21837583 | T/C | 5.93E-7 | 132 | 46.3 | 36.7 | 14.42 | KM Plot |
| TGCT | rs56665180 | chr20:58153881 | C/T | 4.65E-13 | 129 | 42.1 | 76.63 | 17.1 | KM Plot |
| TGCT | rs567166 | chr13:21837519 | T/C | 5.93E-7 | 132 | 46.3 | 36.7 | 14.42 | KM Plot |
| TGCT | rs56780658 | chr5:1797410 | CT/C | 4.04E-7 | 133 | 42.27 | 45.83 | 20.6 | KM Plot |
| TGCT | rs56789266 | chr2:29494555 | C/T | 0 | 134 | 42.27 | 25.02 | 0.57 | KM Plot |
| TGCT | rs56840835 | chr2:29494668 | T/C | 0 | 134 | 42.27 | 25.02 | 0.57 | KM Plot |
| TGCT | rs56902797 | chr6:41349029 | G/A | 1.36E-6 | 129 | 45.1 | 25.18 | 11.53 | KM Plot |
| TGCT | rs56934076 | chr2:54789016 | T/TAA | 7.54E-5 | 130 | 46.3 | 41.97 | 22.42 | KM Plot |
| TGCT | rs57204212 | chr6:28335007 | C/A | 0 | 134 | 45.83 | 29.65 | 0.57 | KM Plot |
| TGCT | rs57290849 | chr6:42540230 | A/AT | 3.69E-9 | 131 | 19.33 | 51.67 | 37.95 | KM Plot |
| TGCT | rs57339942 | chr14:71083307 | T/A | 1.69E-5 | 131 | 39.38 | 66.9 | 21.43 | KM Plot |